NCT04714190 2023-12-21
A Study of RC48-ADC in Local Advanced or Metastatic Gastric Cancer With the HER2-Overexpression
RemeGen Co., Ltd.
Phase 3 Unknown
RemeGen Co., Ltd.
Medical University of Lublin
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Beijing Friendship Hospital